HPV is the cause of 5% of all cancers, worldwide. A highly efficacious and safe HPV vaccine to prevent HPV infection has been available in the US since 2006, yet vaccination
A five-year collaboration between Mass Eye and Ear, The Broad Institute, Mass General and Biotech Calico has launched with the overarching goal of improving treatments for head and neck cancer.
What happens to ctHPVDNA immediately after surgery for an HPV-associated cancer? HPV+OPSCC is increasing at epidemic proportions and is commonly treated with transoral robotic surgery(TORS). A new manuscript published by
HPV-associated head and neck cancer blood test shows promise as a test to replace tissue biopsy Liquid biopsy test developed at Mass Eye and Ear was more accurate, faster and
The incidence of HPV related head and neck cancers (HPV+ HNC) is increasing significantly in the United States. At the same time, we are now seeing patients present with, or